Nutex Health Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -190.2% | – | +334.6% | -48.8% | -99.2% | +95,231.2% | -46.5% | +265.1% | -29.3% | +7.3% | -54.7% | – | |
| – | -1.3% | -10.6% | +8.3% | +9.7% | +6.2% | -3.6% | +3.1% | -4.7% | +3.7% | +5.9% | -3.2% | – | |
| – | +1,195.9% | -92.3% | -224.6% | – | +647.7% | +88.3% | +184.9% | -83.2% | -119.7% | – | – | – | |
| – | -447.9% | – | +127.8% | -123.2% | – | – | – | – | – | -78.8% | -271.5% | – | |
| – | -71.3% | -11.2% | -23.8% | +10.5% | -36.0% | -83.8% | +1,073.4% | -59.8% | +366.6% | -14.8% | +111.5% | – | |
| – | – | -184.7% | +73.2% | -79.0% | +1,148.6% | -98.1% | – | – | +1,579.5% | -76.3% | +111.5% | – | |
| – | -46.7% | -45.3% | +187.0% | +30.2% | +54.6% | +165.0% | +55.0% | +105.0% | +37.2% | -52.2% | -13.6% | – | |
| – | – | +0.0% | – | – | – | – | – | – | – | +534.6% | -40.3% | – | |
| – | – | – | – | – | +4,866.4% | – | -875.2% | +53.6% | +39.1% | -59.5% | -13.2% | – | |
| – | -8.5% | – | -120.9% | -64.6% | +609.3% | +128.1% | +126.8% | +93.5% | +53.2% | +8.2% | -29.0% | – | |
| – | – | – | +35.0% | -43.5% | -202.7% | – | -72.8% | +477.4% | -71.4% | +24.9% | -114.3% | – | |
| – | – | – | +447.9% | -51.4% | -105.5% | – | -47.9% | +274.3% | -30.5% | +7.7% | -57.4% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.